Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial.
Girard N, Ponce Aix S, Cedres S, Berghmans T, Burgers S, Toffart AC, Popat S, Janssens A, Gervais R, Hochstenbag M, Silva M, Burger IA, Prosch H, Stahel R, Xenophontos E, Pretzenbaher Y, Neven A, Peters S.
Girard N, et al. Among authors: burgers s.
ESMO Open. 2023 Jun;8(3):101576. doi: 10.1016/j.esmoop.2023.101576. Epub 2023 Jun 6.
ESMO Open. 2023.
PMID: 37285717
Free PMC article.
Clinical Trial.